Figure 3.
Heatmap diagram showing ASDAS disease activity status through 104 weeks among patients randomised to (A) placebo (IXE withdrawal), (B) IXE Q4W or (C) IXE Q2W at week 24. Each row corresponds to an individual patient and each column corresponds to a specific week of COAST-Y. ASDAS, Ankylosing Spondylitis Disease Activity Score; IXE, ixekizumab; Q2W, every 2 weeks; Q4W, every 4 weeks.